Kumar Sambamurti to Receptors, Tumor Necrosis Factor, Type II
This is a "connection" page, showing publications Kumar Sambamurti has written about Receptors, Tumor Necrosis Factor, Type II.
Connection Strength
0.058
-
New therapeutic strategies and drug candidates for neurodegenerative diseases: p53 and TNF-alpha inhibitors, and GLP-1 receptor agonists. Ann N Y Acad Sci. 2004 Dec; 1035:290-315.
Score: 0.058